Skip to Main Content

Paper Details

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
J Clin Oncol
138
2018
AML, ASXL1, Acute Myeloid Leukemia, CMC, CR, DNMT3A, Patients, Somatic Mutations, TET2, acute myeloid leukemia, nonpreleukemic genes, patients, variant allele
Author NameAffiliation
Hagop KantarjianThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Xingzhi SongThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Xingzhi SongThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Jianhua ZhangThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Jianhua ZhangThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Curtis GumbsThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Courtney D DiNardoThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Farhad RavandiThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Jorge CortesThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
Phillip A FutrealThe University of Texas MD Anderson Cancer Center, The University of Tokyo, Kyoto University
  • 1 - 11

Datasets